Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasm, Residual × Gynecologic × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 34 Lymphoid 30 Plasma cell 7 Myeloid 7 Breast 7 Tumor-Agnostic 5 Thoracic 4 Gastrointestinal 4 Classical hematology 2 CNS 2 Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 802 Uterine Cervical Neoplasms 406 Fallopian Tube Neoplasms 287 Endometrial Neoplasms 284 Carcinoma, Ovarian Epithelial 250 Neoplasms 94 Recurrence 83 Breast Neoplasms 81 Peritoneal Neoplasms 65 Uterine Neoplasms 55 Colorectal Neoplasms 53 Sarcoma 49 Vulvar Neoplasms 48 Uterine Cervical Dysplasia 48 Neoplasm Metastasis 43 Carcinoma, Non-Small-Cell Lung 42 Stomach Neoplasms 41 Pancreatic Neoplasms 36 Melanoma 33 Testicular Neoplasms 32 Lung Neoplasms 30 Vaginal Neoplasms 28 Prostatic Neoplasms 28 Carcinoma 25 Papillomavirus Infections 23 Head and Neck Neoplasms 23 Esophageal Neoplasms 23 Carcinoma, Renal Cell 22 Urinary Bladder Neoplasms 21 Small Cell Lung Carcinoma 21

Interventions

Neoadjuvant Therapy 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00551577 2007-10-31

PRIMOVAR-1

University Hospital, Bonn

Phase 2 Unknown

Ovarian Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡